Nationwide Recall Issued for Blood Pressure Drug Over Possible Metal Contamination
A U.S. manufacturer has initiated a nationwide consumer-level recall of a blood pressure medication after identifying a potential metal contamination risk in one lot of the product. The action adds to a growing list of pharmaceutical quality-control incidents that can disrupt supply chains, unsettle patients, and draw heightened scrutiny from regulators and wholesalers.
